FDA approves debated Alzheimer’s drug panned by experts

Government health officials on Monday approved the first new drug for Alzheimer’s disease in nearly 20 years, disregarding warnings from independent advisers.

Google $268M by France for unfair online ads treatment

France’s anti-competition watchdog decided Monday to fine Google 220 million euros ($268 million) for abusing its “dominant position” in the online advertising business.